Cargando…

Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib

As new treatment approaches, both immunotherapy and targeted treatments have been used in the clinical treatment of cancers. These therapies are different from traditional surgery, chemotherapy and radiotherapy. Use of a combination of immunotherapy and targeted treatments may improve tumor clearanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ningning, Zhong, Jingjing, Wang, Xiaodong, Jin, Zhenchao, Li, Wang, Liu, Yu, Diao, Yuwen, Wang, Zhulin, Jiang, Wenqi, Jin, Guangyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175151/ https://www.ncbi.nlm.nih.gov/pubmed/28000738 http://dx.doi.org/10.1038/srep39598

Ejemplares similares

Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
por: Wang, Xiaodong, et al.
Publicado: (2018)

Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects
por: Liu, Yu, et al.
Publicado: (2020)

Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity
por: Ren, Sumei, et al.
Publicado: (2022)

A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model
por: Hu, Yunlong, et al.
Publicado: (2020)

Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma
por: Zhu, Jiang, et al.
Publicado: (2015)

Breast Cancer Vaccine Containing a Novel Toll-like Receptor 7 Agonist and an Aluminum Adjuvant Exerts Antitumor Effects
por: Zhang, Shuquan, et al.
Publicado: (2022)

Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer
por: Liu, Bing, et al.
Publicado: (2016)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
por: Chi, Huju, et al.
Publicado: (2022)

Conjugation of TLR7 Agonist Combined with Demethylation Treatment Improves Whole-Cell Tumor Vaccine Potency in Acute Myeloid Leukemia
por: Zhong, Guocheng, et al.
Publicado: (2020)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals
por: Wang, Jun, et al.
Publicado: (2020)

Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors
por: Díaz-Carballo, David, et al.
Publicado: (2021)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma
por: Lin, Guimiao, et al.
Publicado: (2015)

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages
por: Yoshida, Sumito, et al.
Publicado: (2017)

Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation
por: Huo, Zhi-Jun, et al.
Publicado: (2015)

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020)

Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell
por: Buss, Julieti Huch, et al.
Publicado: (2019)

Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity
por: Manna, Saikat, et al.
Publicado: (2020)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8
por: Wang, Xiaoyu, et al.
Publicado: (2022)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
por: Zhang, Li, et al.
Publicado: (2015)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
por: Cheadle, E J, et al.
Publicado: (2017)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
por: Naushad, Shaik Mohammad, et al.
Publicado: (2023)

TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
por: REN, XINGBIN, et al.
Publicado: (2016)

Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8(+) T cell cytotoxicity over BEMPEG+RT
por: Rolig, Annah S, et al.
Publicado: (2022)

Antitumor Potential of Immunomodulatory Natural Products
por: Nuzzo, Genoveffa, et al.
Publicado: (2022)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
por: Mashhadi Abolghasem Shirazi, Maryam, et al.
Publicado: (2023)

Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
por: Cheadle, E J, et al.
Publicado: (2017)

Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model
por: Gao, Dong, et al.
Publicado: (2017)

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
por: Haderski, Gary J., et al.
Publicado: (2020)

Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice
por: Schapovalova, Olesia, et al.
Publicado: (2022)

TLR agonist–Stat3 siRNA conjugates: cell-specific gene silencing and enhanced antitumor immune responses
por: Kortylewski, Marcin, et al.
Publicado: (2009)

Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats
por: Wang, Chunhua, et al.
Publicado: (2018)

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012)

Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
por: Smirnov, DV, et al.
Publicado: (2013)

TLR7 Agonist GS–9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV(SF162P3)-Infected Rhesus Monkeys
por: Cong, Zhe, et al.
Publicado: (2023)

Antitumoral and Immunomodulatory Effect of Mahonia aquifolium Extracts
por: Andreicuț, Andra Diana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h9l4pfjit973g47a32tc7cf7mf